Alzamend Neuro, Inc. ALZN
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.59M | 710.70K | 2.71M | 4.45M | 5.62M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 663.40K | 1.05M | 986.10K | 272.00K | 308.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 8.25M | 1.76M | 3.70M | 4.72M | 5.93M |
|
|
|||||
| Total Current Assets | 8.25M | 1.76M | 3.70M | 4.72M | 5.93M |
| Net Property, Plant & Equipment | 287.20K | 314.90K | 342.60K | 370.20K | 397.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 8.54M | 2.08M | 4.04M | 5.09M | 6.33M |
|
|
|||||
| Total Accounts Payable | 2.74M | 1.35M | 1.86M | 717.50K | 983.30K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.74M | 1.35M | 1.86M | 717.50K | 983.30K |
|
|
|||||
| Total Current Liabilities | 2.74M | 1.35M | 1.86M | 717.50K | 983.30K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.74M | 1.35M | 1.86M | 717.50K | 983.30K |
|
|
|||||
| Common Stock & APIC | 76.14M | 68.04M | 66.62M | 66.61M | 66.58M |
| Retained Earnings | -70.33M | -67.31M | -64.44M | -62.24M | -61.24M |
| Treasury Stock & Other | 0.00 | -- | -- | -- | -- |
| Total Common Equity | 5.80M | 733.20K | 2.18M | 4.37M | 5.34M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.80M | 733.20K | 2.18M | 4.37M | 5.34M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.80M | 733.20K | 2.18M | 4.37M | 5.34M |
|
|
|||||